--SuPERIOR Trial--

NCT06191250 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Study Terminated Prior to trial activation, due to changes in SOC of the treatment

Conditions

Non-Small Cell Lung Cancer (NSCLC)
Clinical Staging T2b-3 N0-1 M0

Interventions

DRUG: Durvalumab
RADIATION: Non-ablative oligofractionated radiation (NORT)

Sponsor

University Health Network, Toronto

Collaborators

[object Object]